Filter results
You can narrow down the results using the filters
Health topics
Conditions and diseases
Year
Our work
9296 results
-
COVID-19 outbreaks in Australian residential aged care facilities
This weekly report provides a snapshot of data on the impact of COVID-19 in residential aged care facilities nationally. The report includes data on the number of services impacted and number of staff and resident cases, as well as workforce, vaccine rollout, testing and PPE provided to services. -
COVID-19 outbreaks in Australian residential aged care facilities – 27 January 2023
This weekly report provides a snapshot of data on the impact of COVID-19 in residential aged care facilities nationally. The report includes data on the number of services impacted and number of staff and resident cases, as well as workforce, testing and PPE provided to affected services. -
Outcomes of the hospital treatment certification and dual listed MBS items meeting – September 2022
This fact sheet provides our position on the hospital treatment certification. -
Improving communication, coordination and collaboration amongst alcohol and other drug treatment funders
This document looks at the improvements to the National Framework for Alcohol, Tobacco and other Drug Treatment. It looks at improving processes for communication, coordination, and collaboration (CCC) between and amongst alcohol and other drug (AOD) treatment funders. -
COVID-19 vaccination – Geographic vaccination rates – LGA – Indigenous population
These reports delivered weekly on Fridays, list the percentage of people who have self-identified as Indigenous who have been vaccinated against COVID-19 by local government area (LGA). -
COVID-19 vaccination – Geographic vaccination rates – LGA
These reports list the percentage of people who have been vaccinated against COVID-19 by local government area (LGA). -
COVID-19 vaccination – Geographic vaccination rates – SA4 Indigenous population – 25 January 2023
This report lists the percentage of people who have self identified as Indigenous who have been vaccinated against COVID-19, by SA4. The percentages are further broken down by geographic regions and whether they've had one dose or are fully vaccinated. -
COVID-19 vaccination – Geographic vaccination rates (LGA) – 25 January 2023
These reports list the percentage of people who have been vaccinated against COVID-19 by local government area (LGA). -
COVID-19 vaccination – vaccination data
These data files contains statistical data about Australia's COVID-19 vaccinations. -
COVID-19 vaccination rollout update
These presentations contain high-level data about Australia's COVID-19 vaccination rollout program. -
COVID-19 vaccine rollout update – 25 January 2023
This presentation, delivered on 25 January 2023, contains an update to Australia's COVID-19 vaccine rollout. -
COVID-19 vaccination – vaccination data – 25 January 2023
This data file contains statistical data about Australia's COVID-19 vaccinations. -
Japanese encephalitis virus – Public relations material
This suite of materials for the 'Japanese encephalitis virus' campaign encourages Australians to cover up, use insect repellent and use a screen or net. -
COVID-19 Vaccines in Australia – A3 poster
This poster provides key differences between each COVID-19 vaccine approved for use in Australia as per the Australian Technical Advisory Group on Immunisation (ATAGI) guidelines. -
What is AN-ACC Class 1 (Admit for Palliative Care)?
This fact sheet explains the separate funding class for individuals who enter residential care for the purpose of receiving palliative care. -
Prostheses List Management System (PLMS)
Sponsors and suppliers can use the PLMS to create, edit and monitor applications for prostheses listings. -
Coronavirus (COVID-19) common operating picture
A collection of weekly infographics that provide a traffic light report of the coronavirus (COVID-19) situation across Australia. -
Coronavirus (COVID-19) common operating picture – 27 January 2023
This infographic issued on 27 January 2023 provides a weekly traffic light report of the coronavirus (COVID-19) situation across Australia. -
Life Saving Drugs Program resources – Gaucher disease
A collection of resources for health professionals to help people with Gaucher disease (type 1) access the following drugs under the Life Saving Drugs Program: imiglucerase (Cerezyme®), velaglucerase (VPRIV®), and taliglucerase (Elelyso®). -
Life Saving Drugs Program resources – Mucopolysaccharidosis type II (MPS II)
A collection of resources for health professionals to help people with mucopolysaccharidosis type II (MPS II) access idursulfase (Elaprase®) under the Life Saving Drugs Program. -
Life Saving Drugs Program resources – Pompe disease
A collection of resources for health professionals to help people with Pompe disease access alglucosidase alfa (Myozyme®) and avalglucosidase alfa (Nexviazyme®) under the Life Saving Drugs Program. -
Life Saving Drugs Program – Pompe disease – Review summary and expert panel recommendations for consumers
This Pompe disease review considered alglucosidase alfa. The Expert Panel considered this review at its October 2020 meeting. This document provides a summary of the review findings and recommendations in plain English for health consumers. -
Life Saving Drugs Program – Pompe disease – Review summary and expert panel recommendations
This Pompe disease review considered alglucosidase alfa. The Expert Panel considered this review at its October 2020 meeting. This document provides a summary of the review findings and recommendations. -
Life Saving Drugs Program – MPS II – Review summary and expert panel recommendations for consumers
This MPS II review considered idursulfase. The Expert Panel considered this review at its October 2020 meeting. This document provides a summary of the review findings and recommendations in plain English for health consumers. -
Life Saving Drugs Program – MPS II – Review summary and expert panel recommendations
This MPS II review considered idursulfase. The Expert Panel considered this review at its October 2020 meeting. This document provides a summary of the review findings and recommendations.